The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Friday, February 28, 2020
Active Motif Shanghai, in collaboration with Fudan University and its affiliated Public Health Clinical Center, used its single-cell AbEpic screening ...
read more
AbbVie announced the trial of VENCLEXTA in combination with low-dose cytarabine versus LDAC in combination with placebo did not meet its primary ...
read more
Wednesday, March 04, 2020
WPD has provided an update that through its license partner, CNS, it received positive feedback from the FDA for its Pre-IND meeting proposal to use a...
read more
Wednesday, March 04, 2020
AstraZeneca Pharmaceuticals
NCCN Oncology Research Program announced three research projects selected to receive funding to improve healthcare provider performance and/or ...
read more
EpiVax announces a collaboration to develop a novel coronavirus (COVID-19) vaccine with University of Georgia’s Ted Ross (Director, Center for ...
read more
American BriVision announced the first patient enrollment of ABV-1505 Phase II Part I clinical trial, under the FDA clinical protocol code BLI-1008-...
read more
Over the past year, the FDA has embarked on a comprehensive evaluation of CBD products, with a focus on educating the public about the risks and ...
read more
Mologic has been awarded circa £1 million by the Wellcome Trust and the DFID, as part of the UK government’s £46 million international coronavirus (...
read more
Out of an abundance of caution we’ve made the difficult decision to cancel DCAT Week 2020.
read more
The FDA approved Isturisa oral tablets for adults with Cushing’s disease who either cannot undergo pituitary gland surgery or have undergone the ...
read more
The FDA approved Ofev (nintedanib) oral capsules to treat patients with chronic fibrosing interstitial lung diseases with a progressive phenotype.
read more
MediciNova announced it plans to initiate development of MN-166 (ibudilast) for severe pneumonia and acute respiratory distress syndrome (ARDS).
read more
Takeda announced the results from the TOURMALINE-MM2 study designed to evaluate the addition of NINLARO to lenalidomide and dexamethasone in newly ...
read more
Wednesday, March 11, 2020
International Pharmaceutical Expo (INTERPHEX) will be postponed due to the COVID-19 virus.
read more
Wednesday, March 11, 2020
Spero announced the FDA has granted orphan drug designation for oral SPR720 for the treatment of nontuberculous mycobacterial infection.
read more